Spots Global Cancer Trial Database for germ cell tumors
Every month we try and update this database with for germ cell tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors | NCT00572572 | Germ Cell Tumor... | Aprepitant Placebo | 15 Years - | Hoosier Cancer Research Network | |
| A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies | NCT02571036 | Gastrointestina... Advanced System... Advanced Cancer... | DCC-2618 DCC-2618 | 18 Years - | Deciphera Pharmaceuticals LLC | |
| Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors | NCT02390843 | Retinoblastoma Clear Cell Sarc... Renal Cell Carc... Rhabdoid Tumor Wilms Tumor Hepatoblastoma Neuroblastoma Germ Cell Tumor... Ewings Sarcoma Non-rhabdomyosa... Osteosarcoma Rhabdomyosarcom... | Simvastatin Cyclophosphamid... Topotecan Myeloid growth ... | 1 Year - 29 Years | Emory University | |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT01966913 | Germ Cell Tumor | Bevacizumab ICE chemotherap... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors | NCT02536183 | Pediatric Cance... Solid Tumors Rhabdomyosarcom... Ewing Sarcoma Soft Tissue Sar... Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor... | Magnetic resona... Lyso-thermosens... | - 30 Years | Children's National Research Institute | |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors | NCT02076906 | Relapsed Pediat... Refractory Pedi... Rhabdomyosarcom... Ewing Sarcoma Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor Desmoid Tumor | Magnetic Resona... | - 30 Years | Children's National Research Institute | |
| Molecular-Guided Therapy for Childhood Cancer | NCT02162732 | Neuroblastoma Medulloblastoma Glioma Ependymoma Choroid Plexus ... Craniopharyngio... Dysembryoplasti... Meningioma Primitive Neuro... Germ Cell Tumor... Rhabdomyosarcom... Non-rhabdomyosa... Ewings Sarcoma Osteosarcoma Wilms Tumor Renal Cell Carc... Malignant Rhabd... Clear Cell Sarc... Liver Tumors | Guided Therapy | 13 Months - 21 Years | Milton S. Hershey Medical Center | |
| Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors | NCT03868176 | Follow-up Compliance, Pat... Text Messaging Germ Cell Tumor | short message s... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors | NCT02536183 | Pediatric Cance... Solid Tumors Rhabdomyosarcom... Ewing Sarcoma Soft Tissue Sar... Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor... | Magnetic resona... Lyso-thermosens... | - 30 Years | Children's National Research Institute | |
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT02161692 | Testicular Neop... Germ Cell Tumor... | Cyclophosphamid... Etoposide Cisplatin Bleomycin Carboplatin | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors. | NCT04283773 | Ovarian Neoplas... Germ Cell Tumor... Immunohistochem... | p16INK4a Recomb... Ki67 antibody (... | 6 Months - 1 Year | Assiut University | |
| Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies | NCT04648826 | Sarcomas Melanomas Germ Cell Tumor... Epithelial Mali... Pulmonary Metas... | AeroEclipse II ... Bintrafusp alfa Azacytidine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT01966913 | Germ Cell Tumor | Bevacizumab ICE chemotherap... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | NCT00187109 | Germ Cell Tumor... Hepatic Cancer Neuroblastoma Osteosarcoma Rhabdomyosarcom... | Recombinant Hum... | - 21 Years | St. Jude Children's Research Hospital | |
| A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR | NCT00198159 | Refractory Germ... | ZD1839 Iressa | 15 Years - | Indiana University | |
| A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies | NCT02571036 | Gastrointestina... Advanced System... Advanced Cancer... | DCC-2618 DCC-2618 | 18 Years - | Deciphera Pharmaceuticals LLC | |
| Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors | NCT01743482 | Germ Cell Tumor... Measurable Dise... | Pazopanib | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors | NCT02390843 | Retinoblastoma Clear Cell Sarc... Renal Cell Carc... Rhabdoid Tumor Wilms Tumor Hepatoblastoma Neuroblastoma Germ Cell Tumor... Ewings Sarcoma Non-rhabdomyosa... Osteosarcoma Rhabdomyosarcom... | Simvastatin Cyclophosphamid... Topotecan Myeloid growth ... | 1 Year - 29 Years | Emory University | |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors | NCT02076906 | Relapsed Pediat... Refractory Pedi... Rhabdomyosarcom... Ewing Sarcoma Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor Desmoid Tumor | Magnetic Resona... | - 30 Years | Children's National Research Institute | |
| Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis | NCT00864318 | Germ Cell Tumor... | Paclitaxel Ifosfamide Carboplatine Etoposide cytapheresis + ... | 18 Years - | Institut Claudius Regaud | |
| Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT02161692 | Testicular Neop... Germ Cell Tumor... | Cyclophosphamid... Etoposide Cisplatin Bleomycin Carboplatin | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
